MEDICAL POLYMERS MARKET ANALYSIS

Medical Polymers Market, By Product (Fibers and resin, (PVC, PP, PE, PS, and Others (engineering thermoplastics such as nylon, PET, PA, PC, ABS)), Medical Elastomers (Styrenic Block Copolymer, Rubber latex (NR + Butyl Rubber + Silicone rubber), Others (TPU, TPO, TPV)), Biodegradable plastics), By Application (Medical devices and equipment’s, Medical packaging, and Others (cardio, tissue culture)) and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa)

Published In : Jul 2023
Code : CMI4163
Pages :157
Formats :
Excel and PDF
Industry : Polymers and Resins

Market News

Global Medical Polymer Market: Recent Developments

In August 2021- Parent companies, Cargill and GC, authorized NatureWorks to invest over US$ 600 million in the new fully integrated 75,000 ton-per-year facility, which includes lactic acid, lactide, and polymer manufacturing sites planned for construction beginning in the second quarter of 2022.

In March 2023, Natureworks Celebrates Construction Milestone For New Fully Integrated Ingeo PLA Biopolymer Manufacturing Facility In Thailand

In January 2023, BASF announced an investment in the capacity expansion of polymer dispersions at its production site in Merak, Indonesia. The expansion is in line with the growing trend of high-quality packaging in ASEAN where key paper and board manufacturers are located.

In June 2023, Sumitomo Chemical decided to build additional production lines for its liquid crystal polymer (LCP) SUMIKASUPERTM, which is a super engineering Polymer, at its Ehime Works (Niihama city, Ehime, Japan). In the Sumitomo Chemical Group, LCP is produced at Sumitomo Chemical’s Ehime Works and the Harima Works of the Company’s subsidiary Taoka Chemical Co., Ltd. (Harima, Kako-gun, and Hyogo, Japan).